10x Genomics, Inc.
TXG
$20.92
$0.422.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -22.66M | -43.54M | -76.32M | -84.60M | -157.04M |
| Total Depreciation and Amortization | 43.96M | 42.02M | 40.49M | 38.99M | 40.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 104.57M | 112.63M | 119.37M | 126.36M | 137.71M |
| Change in Net Operating Assets | 1.95M | 24.94M | 4.99M | -13.79M | 35.83M |
| Cash from Operations | 127.82M | 136.05M | 88.53M | 66.95M | 56.74M |
| Capital Expenditure | -5.64M | -5.94M | -6.87M | -10.08M | -11.38M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -9.27M | -9.27M | -8.62M | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.05M | 1.77M | -47.74M | -47.97M | -33.78M |
| Cash from Investing | -12.86M | -13.44M | -63.23M | -58.04M | -45.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.65M | 6.80M | 9.08M | 8.62M | 9.70M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -8.69M | -- | -- | -- | -- |
| Cash from Financing | -2.04M | 6.80M | 9.08M | 8.62M | 9.70M |
| Foreign Exchange rate Adjustments | 297.00K | 484.00K | 172.00K | 361.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 113.22M | 129.90M | 34.55M | 17.89M | 21.28M |